Загрузка...
‘Me-Too’ Innovation in Pharmaceutical Markets()
Critics of me-too innovation often argue that follow-on drugs offer little incremental clinical value over existing pioneer products, while at the same time increasing health care costs. We examine whether consumers view follow-on and pioneer drugs as close substitutes or distinct clinical therapies...
Сохранить в:
| Опубликовано в: : | Forum Health Econ Policy |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659838/ https://ncbi.nlm.nih.gov/pubmed/29081727 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|